Notes for CBS 6 Kratom Interview

Intent of the Kratom Consumer Protection Bill

This bill is not a ban.

It does not make the sale, purchase, or consumption of non-synthetic kratom illegal. Adults over 21 may continue to legally access kratom products.

The purpose of this legislation is consumer protection and informed choice.

---

Executive Summary

Summary

This legislation:

• Does not ban kratom

• Preserves adult access

• Improves transparency

• Protects young people

• Promotes informed choice

It ensures that Virginians have the knowledge and safeguards they deserve when making decisions about kratom use.

---

1. Clear and Informative Warning Labels

The bill requires stronger, more informative labeling that explains the potential risks of kratom use.

• Many consumers begin using kratom without understanding its addictive and dependency risks.

• Current packaging often minimizes or omits these risks.

• Consumers deserve accurate, visible information before purchase.

This provision ensures buyers can make informed decisions.

---

2. Behind-the-Counter Storage

The bill requires kratom products to be stored behind the counter, similar to tobacco products.

• This does not make kratom illegal for adults.

• It treats kratom like other potentially addictive substances.

• It creates a mental and physical barrier that encourages thoughtful purchase.

This helps distinguish kratom from ordinary convenience products and signals potential risk.

3. Stronger Age Enforcement (21+)

The bill strengthens enforcement of the existing age restriction.

• Prevents access by minors.

• Encourages retailer compliance.

• Reduces early exposure and dependency risk.

This aligns kratom regulation with other controlled consumer products.

---

Core Purpose: Consumer Protection

Many people begin using kratom with little understanding of:

• How it affects the brain and body

• Its potential for dependency

• Its interaction with other substances

• Long-term health risks

Unlike tobacco, alcohol, or marijuana, most consumers lack basic public awareness about kratom’s effects.

This bill closes that information gap.

---

Scientific Background: How Kratom Works in the Body

Active Compounds

Kratom (Mitragyna speciosa) contains several psychoactive alkaloids. The most significant are:

• Mitragynine (primary active compound)

• 7-hydroxymitragynine (present in smaller amounts but far more potent)

These compounds are biologically active and affect the central nervous system.

Interaction With Opioid Receptors

Both mitragynine and 7-hydroxymitragynine act on the brain’s mu-opioid receptors, the same receptors affected by:

• Morphine

• Oxycodone

• Heroin

• Fentanyl

While kratom compounds are sometimes described as “partial” or “atypical” agonists, they still:

• Activate opioid pathways

• Reduce pain

• Produce euphoria

• Alter mood and perception

• Create tolerance over time

This means kratom functions, at a biochemical level, as an opioid-like substance.

Dose-Dependent Effects

Kratom’s effects vary by dose:

• Lower doses (often described as “stimulating”):

• Increased alertness

• Mild euphoria

• Elevated heart rate

• Reduced appetite

• Higher doses (opioid-like effects):

• Sedation

• Pain relief

• Relaxation

• Nausea

• Impaired coordination

• Respiratory depression (in some cases)

This dual effect can mislead users into thinking the product is “self-regulating” or low-risk.

Tolerance, Dependence, and Withdrawal

Regular kratom use can produce:

• Tolerance (needing more for the same effect)

• Physical dependence

• Withdrawal symptoms upon stopping

Documented withdrawal symptoms include:

• Anxiety

• Insomnia

• Muscle aches

• Irritability

• Depression

• Nausea

• Cravings

These symptoms are consistent with opioid withdrawal patterns.

Brain Chemistry and Reward Pathways

Kratom affects multiple neurotransmitter systems, including:

• Opioid pathways

• Dopamine (reward and motivation)

• Serotonin (mood regulation)

By activating these systems, kratom reinforces repeated use and increases addiction risk.

This is why dependency can develop even when users initially intend “occasional” use.

Variability and Lack of Standardization

Commercial kratom products vary widely in:

• Alkaloid concentration

• Potency

• Purity

• Contaminants

There is no consistent national standard for:

• Dosage labeling

• Quality control

• Alkaloid content

Two products with the same label may have dramatically different effects.

This unpredictability increases overdose and dependency risk.

Interactions and Health Risks

Kratom can interact dangerously with:

• Alcohol

• Benzodiazepines

• Antidepressants

• Other opioids

• Stimulants

Reported adverse effects include:

• Liver injury

• Seizures

• Heart rhythm disturbances

• Respiratory problems

• Psychiatric symptoms

These risks are often downplayed in promotional materials.

Industry Claims vs. Scientific Evidence

Some advocacy groups claim that kratom is:

• “Non-addictive”

• “Safer than opioids”

• “Impossible to overdose on”

• “Not a real opioid”

These claims are misleading.

Peer-reviewed medical literature shows that:

• Kratom activates opioid receptors

• Dependence occurs

• Withdrawal occurs

• Serious adverse events are documented

While kratom may differ from traditional opioids in structure, it is not pharmacologically benign.